HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduced midazolam clearance must be considered in prolonged coma.

AuthorsR Meierhans, J F Stover, M Béchir, M Keel, R Stocker
JournalAnaesthesia and intensive care (Anaesth Intensive Care) Vol. 36 Issue 6 Pg. 915-6 (Nov 2008) ISSN: 0310-057X [Print] United States
PMID19115666 (Publication Type: Case Reports, Letter)
Chemical References
  • Anesthetics, Intravenous
  • Antidotes
  • Cholinesterase Inhibitors
  • Narcotic Antagonists
  • Naloxone
  • Flumazenil
  • Physostigmine
  • Midazolam
Topics
  • Adult
  • Anesthetics, Intravenous (blood, pharmacokinetics)
  • Antidotes (administration & dosage)
  • Cholinesterase Inhibitors (administration & dosage)
  • Coma (chemically induced)
  • Flumazenil (administration & dosage)
  • Humans
  • Male
  • Metabolic Clearance Rate
  • Midazolam (blood, pharmacokinetics)
  • Naloxone (administration & dosage)
  • Narcotic Antagonists (administration & dosage)
  • Physostigmine (administration & dosage)
  • Time

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: